沉默非肌肉肌球蛋白Ⅱ骨髓间充质干细胞移植对内毒素/脂多糖诱导急性肺损伤大鼠肺细胞外基质的影响

尹希; 周万芳; 侯文佳; 范明枝; 伍国胜; 刘晓彬; 马琪敏; 王玉松; 朱峰

doi:10.3760/cma.j.cn501225-20220212-00024

沉默非肌肉肌球蛋白Ⅱ骨髓间充质干细胞移植对内毒素/脂多糖诱导急性肺损伤大鼠肺细胞外基质的影响

doi: 10.3760/cma.j.cn501225-20220212-00024

1.
张家港市第一人民医院（苏州大学附属张家港医院）烧伤整形科，苏州　　215600
2.
海军军医大学第一附属医院烧伤科，上海　　200433

基金项目:

国家重点研发计划 2019YFA0110601

国家自然科学基金地区科学基金项目 81360292

海军军医大学高等级成果培植计划 2018-CGPZ-B03

详细信息

通讯作者:
朱峰，Email：alexzhufeng0816@vip.sina.com

计量
- 文章访问数: 80
- HTML全文浏览量: 44
- PDF下载量: 0
- 被引次数: 0
出版历程
- 收稿日期: 2022-02-12
- 网络出版日期: 2022-07-20
- 刊出日期: 2022-05-20

Effects of non-muscle myosin Ⅱ silenced bone marrow-derived mesenchymal stem cells transplantation on lung extracellular matrix in rats after endotoxin/lipopolysaccharide-induced acute lung injury

1.
Department of Burns and Plastic Surgery, Zhangjiagang First People's Hospital (the Affiliated Zhangjiagang Hospital of Soochow University), Suzhou 215600, China
2.
Department of Burns, the First Affiliated Hospital of Naval Medical University, Shanghai 200433, China

Funds:

National Key R&D Program of China 2019YFA0110601

Regional Science Fund of National Natural Science Foundation of China 81360292

The High-Level Achievement Cultivation Program of the Naval Medical University 2018-CGPZ-B03

More Information

Corresponding author: Zhu Feng, Email: alexzhufeng0816@vip.sina.com

摘要

摘要:
目的探讨沉默非肌肉肌球蛋白Ⅱ（NMⅡ）基因的骨髓间充质干细胞（BMMSC）对内毒素/脂多糖（LPS）诱导的急性肺损伤（ALI）大鼠肺细胞外基质（ECM）和肺纤维化的影响。
方法采用实验研究方法。取4只1周龄雄性SD大鼠股骨和胫骨骨髓腔细胞并经流式细胞术鉴定为BMMSC。取第3代BMMSC用于后续实验。取细胞，分为用含NMⅡ基因的小干扰RNA序列的pHBLV-U6-ZsGreen-Puro质粒转染的沉默NMⅡ组，转染空载质粒的空载组及未进行任何处理的空白对照组，采用蛋白质印迹法检测干预后72 h的NMⅡ的蛋白表达（样本数为3）。取细胞，于倒置相差显微镜下观察形态；另取细胞，用氯甲基苯甲酰胺（CM-DiⅠ）标记，于倒置荧光显微镜下观察体外细胞标记情况。取20只4周龄雄性SD大鼠，按随机数字表法分为空白对照组、单纯ALI组、ALI+BMMSC组及ALI+沉默NMⅡ的BMMSC组，每组5只大鼠。对空白对照组不进行任何处理，其余3组大鼠均给予LPS诱导ALI。造模后即刻，单纯ALI组大鼠经尾静脉注射1 mL生理盐水，ALI+BMMSC组、ALI+沉默NMⅡ的BMMSC组大鼠分别经尾静脉注入1 mL 1×10⁷个/mL CM-DiⅠ标记的BMMSC、NMⅡ基因沉默的BMMSC，空白对照组大鼠于相同时间点通过尾静脉注射1 mL生理盐水。干预后24 h，取肺组织于倒置荧光显微镜下观察BMMSC肺内归巢情况。干预后24 h、1周、2周，取肺组织行苏木精-伊红染色观察肺部炎症情况，行Masson染色观察肺纤维化程度并采用改良Ashcroft评分法对干预后2周肺纤维化程度进行评分（样本数为5）。采用免疫组织化学法检测干预后2周α平滑肌肌动蛋白（α-SMA）、基质金属蛋白酶2（MMP-2）、MMP-9的含量（样本数均为3），采用酶联免疫吸附测定法检测干预后24 h超氧化物歧化酶（SOD）、丙二醛、髓过氧化物酶（MPO）活性（样本数均为3），采用免疫荧光染色法检测干预后1周CD11b和含表皮生长因子样模块黏蛋白样激素受体1（EMR1）蛋白表达（样本数均为3）。对数据行单因素方差分析、Bonferroni法及Kruskal-Wallis H检验。
结果干预后72 h，沉默NMⅡ组细胞NMⅡ蛋白表达水平显著低于空白对照组和空载组（P值均<0.01）。BMMSC呈长梭形，簇状生长形如旋涡；CM-DiⅠ体外成功标记BMMSC。干预后24 h，ALI+沉默NMⅡ的BMMSC组大鼠肺内细胞归巢现象较ALI+BMMSC组更明显，而空白对照组和单纯ALI组大鼠肺内未见CM-DiⅠ标记的细胞。空白对照组大鼠干预后各时间点肺组织中均未见明显炎症细胞浸润，ALI+BMMSC组和ALI+沉默NMⅡ的BMMSC组大鼠干预后24 h肺组织炎症细胞浸润较单纯ALI组明显减少，且2组大鼠干预后1、2周肺泡壁变薄，局部肺组织有少量淤血。干预后1、2周，单纯ALI组、ALI+BMMSC组和ALI+沉默NMⅡ的BMMSC组大鼠肺组织胶原纤维沉积均较空白对照组明显加重，但ALI+BMMSC组和ALI+沉默NMⅡ的BMMSC组大鼠肺组织胶原纤维沉积均较单纯ALI组显著改善。干预后2周，单纯ALI组、ALI+BMMSC组和ALI+沉默NMⅡ的BMMSC组大鼠肺纤维化改良Ashcroft评分分别为（2.36±0.22）、（1.62±0.16）、（1.06±0.26）分，均明显高于空白对照组的（0.30±0.21）分（P<0.01），ALI+BMMSC组和ALI+沉默NMⅡ的BMMSC组大鼠肺纤维化改良Ashcroft评分均明显低于单纯ALI组（P<0.01），ALI+沉默NMⅡ的BMMSC组大鼠肺纤维化改良Ashcroft评分明显低于ALI+BMMSC组（P<0.01）。干预后2周，与单纯ALI组比较，ALI+BMMSC组、ALI+沉默NMⅡ的BMMSC组大鼠肺组织α-SMA含量均显著下降（P<0.05或P<0.01）。4组大鼠肺组织MMP-2含量均相近（P>0.05）。与空白对照组比较，单纯ALI组大鼠肺组织MMP-9含量显著升高（P<0.01）；与单纯ALI组比较，ALI+BMMSC组、ALI+沉默NMⅡ的BMMSC组大鼠肺组织MMP-9含量均显著降低（P<0.01）。干预后24 h，与空白对照组比较，单纯ALI组、ALI+BMMSC组、ALI+沉默NMⅡ的BMMSC组大鼠肺组织丙二醛、SOD、MPO活性均显著升高（P<0.01）；与单纯ALI组比较，ALI+沉默NMⅡ的BMMSC组大鼠肺组织丙二醛活性显著升高（P<0.05），ALI+BMMSC组、ALI+沉默NMⅡ的BMMSC组大鼠肺组织SOD活性均显著升高（P<0.01）；与ALI+BMMSC组比较，ALI+沉默NMⅡ的BMMSC组大鼠肺组织SOD活性显著降低（P<0.01）。与单纯ALI组比较，ALI+BMMSC组、ALI+沉默NMⅡ的BMMSC组大鼠肺组织MPO活性均显著降低（P<0.01）；与ALI+BMMSC组比较，ALI+沉默NMⅡ的BMMSC组大鼠肺组织MPO活性显著降低（P<0.01）。干预后1周，与其他3组比较，ALI+沉默NMⅡ的BMMSC组大鼠肺组织CD11b蛋白表达显著增加（P<0.05或P<0.01）；4组大鼠肺组织EMR1蛋白表达均相近（P>0.05）。
结论移植沉默NMⅡ基因的BMMSC能更明显改善LPS所致ALI大鼠肺组织ECM成分的活性，重塑其完整性，增强其抗氧化能力，减轻肺损伤和肺纤维化。
- 急性肺损伤 /
- 间充质干细胞 /
- 细胞外基质 /
- 基因沉默 /
- 非肌肉肌球蛋白Ⅱ
Abstract:
Objective To investigate the effects of non-muscle myosin Ⅱ (NMⅡ) gene silenced bone marrow-derived mesenchymal stem cells (BMMSCs) on pulmonary extracellular matrix (ECM) and fibrosis in rats with acute lung injury (ALI) induced by endotoxin/lipopolysaccharide (LPS).
Methods The experimental research methods were adopted. Cells from femur and tibial bone marrow cavity of four one-week-old male Sprague-Dawley rats were identified as BMMSCs by flow cytometry, and the third passage of BMMSCs were used in the following experiments. The cells were divided into NMⅡ silenced group transfected with pHBLV-U6-ZsGreen-Puro plasmid containing small interference RNA sequence of NMⅡ gene, vector group transfected with empty plasmid, and blank control group without any treatment, and the protein expression of NMⅡ at 72 h after intervention was detected by Western blotting (n=3). The morphology of cells was observed by an inverted phase contrast microscope and cells labeled with chloromethylbenzoine (CM-DiⅠ) in vitro were observed by an inverted fluorescence microscope. Twenty 4-week-old male Sprague-Dawley rats were divided into blank control group, ALI alone group, ALI+BMMSC group, and ALI+NMⅡ silenced BMMSC group according to the random number table, with 5 rats in each group. Rats in blank control group were not treated, and rats in the other 3 groups were given LPS to induce ALI. Immediately after modeling, rats in ALI alone group were injected with 1 mL normal saline via tail vein, rats in ALI+BMMSC group and ALI+NMⅡ silenced BMMSC group were injected with 1×10⁷/mL BMMSCs and NMⅡ gene silenced BMMSCs of 1 mL labelled with CM-DiⅠ via tail vein, and rats in blank control group were injected with 1 mL normal saline via tail vein at the same time point, respectively. At 24 h after intervention, the lung tissue was collected to observe intrapulmonary homing of the BMMSCs by an inverted fluorescence microscope. Lung tissue was collected at 24 h, in 1 week, and in 2 weeks after intervention to observe pulmonary inflammation by hematoxylin eosin staining and to observe pulmonary fibrosis by Masson staining, and the pulmonary fibrosis in 2 weeks after intervention was scored by modified Ashcroft score (n=5). The content of α-smooth muscle actin (α-SMA), matrix metalloproteinase 2 (MMP-2), and MMP-9 was detected by immunohistochemistry in 2 weeks after intervention (n=3), the activity of superoxide dismutase (SOD), malondialdehyde, myeloperoxidase (MPO) was detected by enzyme-linked immunosorbent assay at 24 h after intervention (n=3), and the protein expressions of CD11b and epidermal growth factor like module containing mucin like hormone receptor 1 (EMR1) in 1 week after intervention were detected by immunofluorescence staining (n=3). Data were statistically analyzed with one-way analysis of variance, Bonferroni method, and Kruskal-Wallis H test.
Results At 72 h after intervention, the NMⅡprotein expression of cells in NMⅡ silenced group was significantly lower than those in blank control group and vector group (with P values <0.01). BMMSCs were in long spindle shape and grew in cluster shaped like vortexes, which were labelled with CM-DiⅠ successfully in vitro. At 24 h after intervention, cell homing in lung of rats in ALI+NMⅡ silenced BMMSC group was more pronounced than that in ALI+BMMSC group, while no CM-DiⅠ-labelled BMMSCs were observed in lung of rats in blank control group and ALI alone group. There was no obvious inflammatory cell infiltration in lung tissue of rats in blank control group at all time points, while inflammatory cell infiltration in lung tissue of rats in ALI+BMMSC group and ALI+NMⅡ silenced BMMSC group was significantly less than that in ALI alone group at 24 h after intervention, and alveolar wall turned to be thinner and a small amount of congestion in local lung tissue appeared in rats of the two groups in 1 week and 2 weeks after intervention. In 1 week and 2 weeks after intervention, collagen fiber deposition in lung tissue of rats in ALI alone group, ALI+BMMSC group, and ALI+NMⅡ silenced BMMSC group was significantly aggravated compared with that in blank control group, while collagen fiber deposition in lung tissue of rats in ALI+BMMSC group and ALI+NMⅡ silenced BMMSC group was significantly improved compared with that in ALI alone group. In 2 weeks after intervention, modified Ashcroft scores for pulmonary fibrosis of rats in ALI alone group, ALI+BMMSC group, and ALI+NMⅡ silenced BMMSC group were 2.36±0.22, 1.62±0.16, 1.06±0.26, respectively, significantly higher than 0.30±0.21 in blank control group (P<0.01). Modified Ashcroft scores for pulmonary fibrosis of rats in ALI+BMMSC group and ALI+NMⅡ silenced BMMSC group were significantly lower than that in ALI alone group (P<0.01), and modified Ashcroft score for pulmonary fibrosis of rats in ALI+NMⅡ silenced BMMSC group was significantly lower than that in ALI+BMMSC group (P<0.01). In 2 weeks after intervention, the content of α-SMA in lung tissue of rats in ALI+BMMSC group and ALI+NMⅡ silenced BMMSC group were significantly decreased compared with that in ALI alone group (P<0.05 or P<0.01). The content of MMP-2 in lung tissue of rats in the 4 groups was similar (P>0.05). The content of MMP-9 in lung tissue of rats in ALI alone group was significantly increased compared with that in blank control group (P<0.01), and the content of MMP-9 in lung tissue of rats in ALI+BMMSC group and ALI+NMⅡ silenced BMMSC group was significantly decreased compared with that in ALI alone group (P<0.01). At 24 h after intervention, the activity of malondialdehyde, SOD, and MPO in lung tissue of rats in ALI alone group, ALI+BMMSC group, and ALI+NMⅡ silenced BMMSC group were significantly increased compared with that in blank control group (P<0.01), the activity of malondialdehyde in lung tissue of rats in ALI+NMⅡ silenced BMMSC group and the activity of SOD in lung tissue of rats in ALI+BMMSC group and ALI+NMⅡ silenced BMMSC group were significantly increased compared with that in ALI alone group (P<0.05 or P<0.01), and the activity of SOD in lung tissue of rats in ALI+NMⅡ silenced BMMSC group was significantly decreased compared with that in ALI+BMMSC group (P<0.01). The activity of MPO in lung tissue of rats in ALI+BMMSC group and ALI+NMⅡ silenced BMMSC group was significantly decreased compared with that in ALI alone group (P<0.01), and the activity of MPO in lung tissue of rats in ALI+NMⅡ silenced BMMSC group was significantly decreased compared with that in ALI+BMMSC group (P<0.01). In 1 week after intervention, the protein expression of CD11b in lung tissue of rats in ALI+NMⅡ silenced BMMSC group was significantly increased compared with those in the other three groups (P<0.05 or P<0.01), while the protein expressions of EMR1 in lung tissue of rats in the four groups were similar (P>0.05).
Conclusions Transplantation of NMⅡ gene silenced BMMSCs can significantly improve the activity of ECM components in the lung tissue in LPS-induced ALI rats, remodel its integrity, and enhance its antioxidant capacity, and alleviate lung injury and pulmonary fibrosis.
- Acute lung injury /
- Mesenchymal stem cells /
- Extracellular matrix /
- Gene silencing /
- Non-muscle myosin Ⅱ
尹希：设计实验，撰写文章；周万芳：实施研究，撰写文章；侯文佳：采集数据；范明枝：采集数据和统计分析；伍国胜：分析、解释数据；刘晓彬：实施研究；马琪敏：实施研究，分析、解释数据；王玉松：实施研究，分析、解释数据；朱峰：对文章的知识性内容作批评性审阅，获取研究经费，负责行政、技术和材料支持

所有作者均声明不存在利益冲突

严重烧伤常引起各种全身并发症和MODS，这些是造成患者死亡的主要原因。烧伤后MODS患者的肺和肾是易受损器官。体外膜氧合(ECMO)和连续性肾脏替代治疗(CRRT)已逐渐被应用于临床，对伴难治性呼吸衰竭或肾功能不全的重度烧伤患者有益，但关于ECMO联合CRRT在重度烧伤救治中应用的报道较少。陆军军医大学（第三军医大学）第一附属医院罗高兴教授团队在《Burns & Trauma》发文《Extracorporeal membrane oxygenation combined with continuous renal replacement therapy for the treatment of severe burns: current status and challenges》。该文重点介绍ECMO联合CRRT在严重烧伤救治中应用的现状及相关挑战，提出CRRT应用时机在休克期，但因严重烧伤患者有低血容量及低灌注等情况，需综合评估治疗时机。该文同时建议放置鼻胃管或鼻空肠管，加强肠内营养支持，避免营养不良；可应用肝素抗凝，但应注意其引起的创面出血并寻找肝素的最佳使用剂量；可通过加强导管部位换药、缩短导管更换时间、局部应用抗生素，避免导管相关感染；根据病情，个体化应用抗菌药物等。该文提出，目前ECMO联合CRRT用于严重烧伤救治的临床研究较少，需开展大样本多中心临床研究。

李江锋，编译自《Burns Trauma》，2021，9：tkab017；郇京宁，审校

HTML全文

下载: 全尺寸图片幻灯片

1 蛋白质印迹法检测3组大鼠骨髓间充质干细胞干预后72 h NMⅡ蛋白表达

注：NMⅡ为非肌肉肌球蛋白Ⅱ，GAPDH为3-磷酸甘油醛脱氢酶；条带上方1为空白对照组，2为空载组，3为沉默NMⅡ组

下载: 全尺寸图片幻灯片

2 大鼠骨髓间充质干细胞（BMMSC）形态及CM-DiⅠ标记BMMSC情况。2A.细胞呈长梭形，簇状生长形如旋涡倒置相差显微镜×100，图中标尺为100 μm；2B.CM-DiⅠ成功标记细胞 CM-DiⅠ-DAPI×100，图中标尺为100 μm

注：细胞膜氯甲基苯甲酰胺（CM-DiⅠ）染色为红色，细胞核4′，6-二脒基-2-苯基吲哚（DAPI）染色为蓝色

下载: 全尺寸图片幻灯片

3 4组大鼠干预后24 h骨髓间充质干细胞（BMMSC）的肺内归巢情况 CM-DiⅠ-DAPI×100。3A、3B、3C、3D.分别为空白对照组、单纯急性肺损伤（ALI）组、ALI+BMMSC组、ALI+沉默非肌肉肌球蛋白Ⅱ（NMⅡ）的BMMSC组DAPI染色；3E、3F、3G、3H. 分别为空白对照组、单纯ALI组、ALI+BMMSC组、ALI+沉默NMⅡ的BMMSC组CM-DiⅠ染色，图3E、3F均未见CM-DiⅠ标记的细胞，图3G、3H均可见CM-DiⅠ标记的细胞，且图3H中CM-DiⅠ标记的细胞较图3G明显增加

注：细胞膜氯甲基苯甲酰胺（CM-DiⅠ）染色为红色，细胞核4′，6-二脒基-2-苯基吲哚（DAPI）染色为蓝色

下载: 全尺寸图片幻灯片

4 4组大鼠干预后各时间点肺组织病理学变化苏木精-伊红×100。4A、4B、4C、4D.分别为空白对照组、单纯急性肺损伤（ALI）组、 ALI+骨髓间充质干细胞（BMMSC）组、ALI+沉默非肌肉肌球蛋白Ⅱ（NMⅡ）的BMMSC组干预后24 h，图4A肺泡结构正常，肺泡壁未见明显增厚，未见明显炎症细胞浸润及无出血，图4B、4C、4D均可见炎症细胞浸润；4E、4F、4G、4H.分别为空白对照组、单纯ALI组、ALI+BMMSC组、ALI+沉默NMⅡ的BMMSC组干预后1周，炎症细胞浸润程度分别较图4A、4B、4C、4D无明显改变；4I、4J、4K、4L.分别为空白对照组、单纯ALI组、ALI+BMMSC组、ALI+沉默NMⅡ的BMMSC组干预后2周，图4I炎症细胞浸润情况与图4A、4E相近，图4J、4K、4L炎症细胞浸润分别较图4F、4G、4H更为明显，出血程度加重

下载: 全尺寸图片幻灯片

5 4组大鼠干预后各时间点肺组织纤维化情况 Masson×200。5A、5B、5C、5D.分别为空白对照组、单纯急性肺损伤（ALI）组、ALI+骨髓间充质干细胞（BMMSC）组、ALI+沉默非肌肉肌球蛋白Ⅱ（NMⅡ）的BMMSC组干预后24 h，胶原纤维沉积均相近；5E、5F、5G、5H.分别为空白对照组、单纯ALI组、ALI+BMMSC组、ALI+沉默NMⅡ的BMMSC组干预后1周，图5E胶原纤维沉积较图5A未见明显改变，图5F、5G、5H胶原纤维沉积均较图5E明显加重，但图5G、5H胶原纤维沉积均较图5F有明显减轻；5I、5J、5K、5L.分别为空白对照组、单纯ALI组、ALI+BMMSC组、ALI+沉默NMⅡ的BMMSC组干预后2周，胶原纤维沉积分别与图5E、5F、5G、5H类似

注：细胞核、胶原蛋白着蓝色，细胞质、红细胞着红色

下载: 全尺寸图片幻灯片

6 4组大鼠干预后2周肺纤维化改良Ashcroft评分比较（样本数为5， $\bar{x} \pm s$ ）

注：横坐标下1为空白对照组，2为单纯急性肺损伤（ALI）组，3为ALI+骨髓间充质干细胞（BMMSC）组，4为ALI+沉默非肌肉肌球蛋白Ⅱ的BMMSC组；与空白对照组比较，^aP<0.01；与单纯ALI组比较，^bP<0.01；与ALI+BMMSC组比较，^cP<0.01

下载: 全尺寸图片幻灯片

7 4组大鼠干预后2周肺组织α平滑肌肌动蛋白（α-SMA）、基质金属蛋白酶2（MMP-2）和MMP-9含量二氨基联苯胺-苏木精×100，图中标尺为100 μm。7A、7B、7C、7D.分别为空白对照组、单纯急性肺损伤（ALI）组、ALI+骨髓间充质干细胞（BMMSC）组、ALI+沉默非肌肉肌球蛋白Ⅱ（NMⅡ）的BMMSC组α-SMA含量，图7B中α-SMA含量较图7C、7D显著升高；7E、7F、7G、7H.分别为空白对照组、单纯ALI组、ALI+BMMSC组、ALI+沉默NMⅡ的BMMSC组MMP-2含量，均相近；7I、7J、7K、7L.分别为空白对照组、单纯ALI组、ALI+BMMSC组、ALI+沉默NMⅡ的BMMSC组MMP-9含量，图7J中MMP-9含量较图7I、7K、7L显著升高

注：目的蛋白阳性染色为棕色，细胞核染色为蓝紫色

下载: 全尺寸图片幻灯片

8 4组大鼠干预后2周肺组织α平滑肌肌动蛋白（α-SMA）和基质金属蛋白酶9（MMP-9）含量比较（样本数为3， $\bar{x} \pm s$ ）。8A.α-SMA含量；8B.MMP-9含量

注：横坐标下1为空白对照组，2为单纯急性肺损伤（ALI）组，3为ALI+骨髓间充质干细胞（BMMSC）组，4为ALI+沉默非肌肉肌球蛋白Ⅱ的BMMSC组；图8A中与单纯ALI组比较，^aP<0.05，^bP<0.01；图8B中与空白对照组比较，^aP<0.01；与单纯ALI组比较，^bP<0.01

下载: 全尺寸图片幻灯片

9 4组大鼠干预后1周肺组织CD11b和含表皮生长因子样模块黏蛋白样激素受体1（EMR1）的蛋白表达异硫氰酸荧光素-4′，6-二脒基-2-苯基吲哚×100，图中标尺为100 μm。9A、9B、9C、9D.分别为空白对照组、单纯急性肺损伤（ALI）组、ALI+骨髓间充质干细胞（BMMSC）组、ALI+沉默非肌肉肌球蛋白Ⅱ（NMⅡ）的BMMSC组CD11b蛋白表达，图9A、9B、9C中CD11b蛋白表达均明显低于图9D；9E、9F、9G、9H.分别为空白对照组、单纯ALI组、ALI+BMMSC组、ALI+沉默NMⅡ的BMMSC组EMR1蛋白表达，均相近

注：绿色荧光为目标蛋白，蓝色荧光为细胞核

下载: 全尺寸图片幻灯片

10 4组大鼠干预后1周肺组织CD11b和含表皮生长因子样模块黏蛋白样激素受体1（EMR1）蛋白表达比较（样本数为3， $\bar{x} \pm s$ ）。10A.CD11b蛋白表达；10B.EMR1蛋白表达

注：横坐标下1为空白对照组，2为单纯急性肺损伤（ALI）组，3为ALI+骨髓间充质干细胞（BMMSC）组，4为ALI+沉默非肌肉肌球蛋白Ⅱ的BMMSC组；与空白对照组比较，^aP<0.05；与单纯ALI组比较，^bP<0.01；与ALI+BMMSC组比较，^cP<0.01

下载: 全尺寸图片幻灯片

表1 4组大鼠干预后24 h肺组织丙二醛、SOD、MPO活性比较（ $\bar{x} \pm s$ ）

组别	样本数	丙二醛（nmol/mg）	SOD（U/mg）	MPO（U/mg）
空白对照组	3	1.063±0.017	2.25±0.05	0.371±0.010
单纯ALI组	3	1.849±0.469^a	5.55±0.04^a	0.786±0.017^a
ALI+BMMSC组	3	2.697±0.137^a	19.75±0.19^ac	0.608±0.006^ac
ALI+沉默NMⅡ的BMMSC组	3	2.929±0.441^ab	13.31±0.09^acd	0.480±0.003^acd
F值		20.06	15 084.39	884.20
P值		<0.001	<0.001	<0.001
注：SOD为超氧化物歧化酶，MPO为髓过氧化物酶，ALI为急性肺损伤，BMMSC为骨髓间充质干细胞，NMⅡ为非肌肉肌球蛋白Ⅱ；与空白对照组比较，^aP<0.01；与单纯ALI组比较，^bP<0.05，^cP<0.01；与ALI+BMMSC组比较，^dP<0.01

下载: 导出CSV

参考文献(20)

[1]	WuG,ChangF,FangH,et al.Non-muscle myosin II knockdown improves survival and therapeutic effects of implanted bone marrow-derived mesenchymal stem cells in lipopolysaccharide- induced acute lung injury[J].Ann Transl Med,2021,9(3):262.DOI: 10.21037/atm-20-4851.
[2]	刘名倬,王俊杰,付忠华,等.沉默非肌肉肌球蛋白ⅡA的骨髓间充质干细胞对烟雾吸入性损伤大鼠早期肺损伤的影响[J].中华烧伤杂志,2017,33(12):766-771.DOI: 10.3760/cma.j.issn.1009-2587.2017.12.009.
[3]	刘新民. 急性肺损伤与细胞外基质[J]. 国外医学(呼吸系统分册), 1994, 14(1): 27-29.
[4]	RoccoPR,NegriEM,KurtzPM,et al.Lung tissue mechanics and extracellular matrix remodeling in acute lung injury[J].Am J Respir Crit Care Med,2001,164(6):1067-1071.DOI: 10.1164/ajrccm.164.6.2007062.
[5]	朱峰,郭光华,陈任生,等.骨髓间充质干细胞在烟雾吸入性损伤家兔体内向功能细胞分化的观察[J].中华烧伤杂志,2011,27(2):150-155.DOI: 10.3760/cma.j.issn.1009-2587.2011.02.020.
[6]	吴明,肖永强,刘名倬,等.慢病毒载体介导的 shRNA 沉默非肌肉肌球蛋白重链Ⅱ A对骨髓间充质干细胞旁分泌的影响[J].广东医学,2016,37(16):2377-2383.
[7]	SuzukiT,TadaY,GladsonS,et al.Vildagliptin ameliorates pulmonary fibrosis in lipopolysaccharide-induced lung injury by inhibiting endothelial-to-mesenchymal transition[J].Respir Res,2017,18(1):177.DOI: 10.1186/s12931-017-0660-4.
[8]	ZhouY,HorowitzJC,NabaA,et al.Extracellular matrix in lung development, homeostasis and disease[J].Matrix Biol,2018,73:77-104.DOI: 10.1016/j.matbio.2018.03.005.
[9]	DieffenbachPB,Mallarino HaegerC,RehmanR,et al.A novel protective role for matrix metalloproteinase-8 in the pulmonary vasculature[J].Am J Respir Crit Care Med,2021,204(12):1433-1451.DOI: 10.1164/rccm.202108-1863OC.
[10]	Abdel HalimAS,AhmedHH,AglanHA,et al.Role of bone marrow-derived mesenchymal stem cells in alleviating pulmonary epithelium damage and extracellular matrix remodeling in a rat model of lung fibrosis induced by amiodarone[J].Biotech Histochem,2021,96(6):418-430.DOI: 10.1080/10520295.2020.1814966.
[11]	朱峰,郭光华,陈雯,等.骨髓间充质干细胞移植对吸入性损伤家兔炎症反应和肺损伤的影响[J].中华烧伤杂志,2010,26(5):360-365.DOI: 10.3760/cma.j.issn.1009-2587.2010.05.010.
[12]	朱峰,郭光华,陈雯,等.骨髓间充质干细胞移植对烟雾吸入性损伤兔肺血管内皮生长因子以及血管生成素1和血管生成素2的影响[J].中华烧伤杂志,2012,28(6):470-472.DOI: 10.3760/cma.j.issn.1009-2587.2012.06.022.
[13]	ZhuF,WangJ,QiuX,et al.Smoke inhalation injury repaired by a bone marrow-derived mesenchymal stem cell paracrine mechanism: angiogenesis involving the Notch signaling pathway[J].J Trauma Acute Care Surg,2015,78(3):565-572.DOI: 10.1097/TA.0000000000000547.
[14]	WalkerA,SuH,ContiMA,et al.Non-muscle myosin II regulates survival threshold of pluripotent stem cells[J].Nat Commun,2010,1:71.DOI: 10.1038/ncomms1074.
[15]	刘名倬.非肌肉肌球蛋白Ⅱ(NMⅡ)的研究进展[J].复旦学报(医学版),2014,41(6):841-845.DOI: 10.3969/j.issn.1672-8467.2014.06.023.
[16]	KovácsM,TóthJ,HetényiC,et al.Mechanism of blebbistatin inhibition of myosin II[J].J Biol Chem,2004,279(34):35557- 35563.DOI: 10.1074/jbc.M405319200.
[17]	WalmaDAC,YamadaKM.The extracellular matrix in development[J].Development,2020,147(10):dev175596. DOI: 10.1242/dev.175596.
[18]	李丛锋,朱光发.基质金属蛋白酶2、基质金属蛋白酶9与急性肺损伤关系的研究进展[J].国际呼吸杂志,2011,31(14):1097-1101.DOI: 10.3760/cma.j.issn.1673-436X.2011.014.016.
[19]	TheocharisAD,SkandalisSS,GialeliC,et al.Extracellular matrix structure[J].Adv Drug Deliv Rev,2016,97:4-27.DOI: 10.1016/j.addr.2015.11.001.
[20]	Jiménez-UribeAP,Gómez-SierraT,Aparicio-TrejoOE,et al.Backstage players of fibrosis: NOX4, mTOR, HDAC, and S1P; companions of TGF-β[J].Cell Signal,2021,87:110123.DOI: 10.1016/j.cellsig.2021.110123.